CA Patent

CA2734295C — Processes for the preparation of sglt2 inhibitors

Assigned to Theracosbio LLC · Expires 2016-12-20 · 9y expired

What this patent protects

Provided are processes for the preparation of complexes that are useful in purifying compounds having an inhibitory effect on sodium-dependent glucose co-transporter SGLT. The processes can reduce the number of steps needed to obtain the target compounds and the complexes formed …

USPTO Abstract

Provided are processes for the preparation of complexes that are useful in purifying compounds having an inhibitory effect on sodium-dependent glucose co-transporter SGLT. The processes can reduce the number of steps needed to obtain the target compounds and the complexes formed in the processes are typically provided in a crystalline form.

Drugs covered by this patent

Patent Metadata

Patent number
CA2734295C
Jurisdiction
CA
Classification
—
Expires
2016-12-20
Drug substance claim
No
Drug product claim
No
Assignee
Theracosbio LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.